Home > News > SurgRx Secures $4.5 Million in Third Round Funding
March 11th, 2004
SurgRx Secures $4.5 Million in Third Round Funding
SurgRx, a developer of proprietary nanotechnology designed to control the delivery of electro surgical energy in surgical sealing instruments, announced today that it has received $4.5 million in C round funding from Prospect Ventures, a venture capital firm focused on investments in biomedical and healthcare innovation. This announcement follows on the heels of the Company's announcement last month that it received $5 million in second round financing from California Technology Ventures.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014